Skip to main content

Published locations for Interleukin-23 inhibition with tildrakizumab achieves significant psoriasis improvements

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Interleukin-23 inhibition with tildrakizumab achieves significant psoriasis improvements

User login

  • Reset your password
  • /content/interleukin-23-inhibition-tildrakizumab-achieves-significant-psoriasis-improvements
  • /edermatologynews/article/97758/psoriasis/interleukin-23-inhibition-tildrakizumab-achieves
  • /rheumatologynews/article/97758/psoriasis/interleukin-23-inhibition-tildrakizumab-achieves
  • /rheumatology/article/97758/psoriasis/interleukin-23-inhibition-tildrakizumab-achieves-significant
  • /dermatology/article/97758/psoriasis/interleukin-23-inhibition-tildrakizumab-achieves-significant
  • /dermatology/psoriasiscollection/article/97758/psoriasis/interleukin-23-inhibition-tildrakizumab
  • /psoriatic-arthritis-icymi/article/97758/psoriasis/interleukin-23-inhibition-tildrakizumab-achieves